SCHEMBL21368053

SCHEMBL21368053

CC(C)(C)OC(=O)C(=N)S

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL78520 0.76 DGAT1 (0.46) DGAT1
SCHEMBL21008320 0.76 DGAT1 (0.37) DGAT1
SCHEMBL3970722 0.74 DGAT1 (0.36) DGAT1
SCHEMBL29399642 0.74
SCHEMBL9784171 0.72 DGAT1 (0.34) DGAT1
SCHEMBL12682757 0.72 DGAT1 (0.34) DGAT1
Thiourea SCHEMBL5840778 0.72 DGAT1 (0.34) DGAT1
SCHEMBL11621321 0.71 DGAT1 (0.42) DGAT1
Hydrazine SCHEMBL10794464 0.71 DGAT1 (0.42) DGAT1
SCHEMBL16045685 0.71 DGAT1 (0.42) DGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019178129-A1 SUBSTITUTED IMIDAZOPYRIDINES AS INHIBITORS OF PLASMA KALLIKREIN AND USES THEREOF SHIRE HUMAN GENETIC THERAPIES, INC. (US) 2019-09-19 WO disclosed